PHC

PHILOCHEM AG

corporate_fareorganization

Web page: http://www.philochem.ch

Country: Switzerland

PHC

- Funding / Projects
  (6)

6 Projects, page 1 of 2

EURENOMICS (European Consortium for High-Throughput Research in Rare Kidney Diseases)
Open Access Mandate for Publications assignment_turned_inProject2012 - 2017Partners:LG, Hacettepe University Hospital, Newcastle University, CMAST, UNIVERSITY OF MICHIGAN THE REGENTS OF THE UNIVERSITY OF MICHIGAN +39 partners
LG,
Hacettepe University Hospital,
Newcastle University,
CMAST,
UNIVERSITY OF MICHIGAN THE REGENTS OF THE UNIVERSITY OF MICHIGAN,
UMC,
UCL,
UZH,
COMPREHENSIVE BIOMARKER CENTER GMBH,
OYS,
CSIC,
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE,
Mario Negri Institute for Pharmacological Research,
LMU,
University Hospital Heidelberg,
UNIVERSITY OF MICHIGAN THE REGENTS OF THE UNIVERSITY OF MICHIGAN,
Hacettepe University,
Genomatix Software GmbH,
MOSAIQUES,
PHC,
PHC,
METABOMETRIX LTD,
KIT,
Philogen (Italy),
MOSAIQUES,
Universitätsklinikum Heidelberg,
Genomatix Software GmbH,
COMPREHENSIVE BIOMARKER CENTER GMBH,
GABO:mi,
CMAST,
STICHTING RADBOUD UNIVERSITEIT,
GABO:mi,
University of Newcastle upon Tyne,
University of Manchester,
ACQUIFER AG,
AP-HP,
Philogen (Italy),
MTP,
University of Bristol,
HKI,
MTP,
KUL,
METABOMETRIX LTD,
ACQUIFER AG
Funder: European Commission Project Code: 305608
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
PRIAT (Profiling Responders In Antibody Therapies)
Open Access Mandate for Publications assignment_turned_inProject2012 - 2014Partners:MUG, Philogen (Italy), Jena University Hospital, PHC, VUA +5 partners
MUG,
Philogen (Italy),
Jena University Hospital,
PHC,
VUA,
UOXF,
University of Tübingen,
PHC,
ETHZ,
Philogen (Italy)
Funder: European Commission Project Code: 305309
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
EUCAAD (European Consortium for Anticancer Antibody Development)
assignment_turned_inProject2008 - 2012Partners:UNITO, MLU, PROTAGEN, LPL, OXURION +7 partners
UNITO,
MLU,
PROTAGEN,
LPL,
OXURION,
BIOINVENT INTERNATIONAL AB,
PROTAGEN,
PHC,
BIOINVENT INTERNATIONAL AB,
PHC,
KI,
University of Chieti-Pescara
Funder: European Commission Project Code: 200755
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
ADAMANT (ANTIBODY DERIVATIVES AS MOLECULAR AGENTS FOR NEOPLASTIC TARGETING)
assignment_turned_inProject2008 - 2011Partners:FONDAZIONE SENDO, Mario Negri Institute for Pharmacological Research, UCL, VUA, KEMOTECH SRL +6 partners
FONDAZIONE SENDO,
Mario Negri Institute for Pharmacological Research,
UCL,
VUA,
KEMOTECH SRL,
ULiège,
PHC,
PHC,
FSU,
FONDAZIONE SENDO,
ETHZ
Funder: European Commission Project Code: 201342
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
ProteinConjugates (A training network for the chemical site-selective modification of proteins: Preparation of the next-generation of therapeutic chemically-defined protein conjugates)
Open Access Mandate for Publications and Research data assignment_turned_inProject2015 - 2019Partners:UR, MPG, PHC, FFUL, THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE +7 partners
UR,
MPG,
PHC,
FFUL,
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE,
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE,
PHC,
Institute Curie,
INSTITUTO DE MEDICINA MOLECULAR,
UCL,
University of Ulm,
University of Vienna
Funder: European Commission Project Code: 675007
Overall Budget: 2,542,770 EURFunder Contribution: 2,542,770 EUR
ProteinConjugates is an inter- and multi-disciplinary network for the education of talented young scientists who will learn how to rationally design and construct the next generation of chemically-defined and innovative protein drug-conjugates for the targeted treatment of serious conditions such as cancer or rheumatoid arthritis. A complementary interaction between academy and pharmaceutical industry is at the centre of such a network, which involves 8 academic groups and 1 SME partner as beneficiaries, and 2 leading European industrial partner organizations that will host secondments while providing training. The combined expertise of the beneficiaries and industrial partners in synthesis of complex molecules, molecular dynamics, supramolecular self-assembly, site-selective chemical protein modification, protein/antibody engineering, cancer therapeutics and drug development together with the experience in project management and training of PhDs and Postdocs of the PIs, will create a multidisciplinary environment where 10 young researchers can foster their knowledge and skills while developing the most innovative ideas in the emerging fields of chemical site-selective protein modification and protein biotherapeutics. Exposure to the highly dynamic and multidisciplinary ProteinConjugates environment will contribute to the education of the next generation of leaders in the emerging field of protein biotherapeutics, a key area of research and drug development for Europe's competitiveness.
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

chevron_left
1
2
chevron_right

PHC

PHC

6 Projects, page 1 of 2

EURENOMICS (European Consortium for High-Throughput Research in Rare Kidney Diseases)

PRIAT (Profiling Responders In Antibody Therapies)

EUCAAD (European Consortium for Anticancer Antibody Development)

ADAMANT (ANTIBODY DERIVATIVES AS MOLECULAR AGENTS FOR NEOPLASTIC TARGETING)

ProteinConjugates (A training network for the chemical site-selective modification of proteins: Preparation of the next-generation of therapeutic chemically-defined protein conjugates)

Loading